U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C26H28N6O.ClH
Molecular Weight 477.001
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NEMIRALISIB HYDROCHLORIDE

SMILES

Cl.CC(C)N1CCN(CC2=CN=C(O2)C3=CC(=CC4=C3C=NN4)C5=CC=CC6=C5C=CN6)CC1

InChI

InChIKey=GECUEJGEJLAXQA-UHFFFAOYSA-N
InChI=1S/C26H28N6O.ClH/c1-17(2)32-10-8-31(9-11-32)16-19-14-28-26(33-19)22-12-18(13-25-23(22)15-29-30-25)20-4-3-5-24-21(20)6-7-27-24;/h3-7,12-15,17,27H,8-11,16H2,1-2H3,(H,29,30);1H

HIDE SMILES / InChI
GSK-2269557 (nemiralisib), a PI3Kδ inhibitor, is in development as an anti-inflammatory drug for the treatment of inflammatory airways disease. Studies in moderate or severe stable COPD patients have shown an acceptable safety and tolerability profile when GSK-2269557 was administered via inhalation. Cough was the most commonly reported adverse event.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
9.9 null [pKi]
Name Type Language
GSK-2269557
Preferred Name English
NEMIRALISIB HYDROCHLORIDE
Common Name English
2-(6-(1H-INDOL-4-YL)-1H-INDAZOL-4-YL)-5-((4-ISOPROPYLPIPERAZIN-1-YL)METHYL)OXAZOLE HYDROCHLORIDE
Systematic Name English
1H-INDAZOLE, 6-(1H-INDOL-4-YL)-4-(5-((4-(1-METHYLETHYL)-1-PIPERAZINYL)METHYL)-2-OXAZOLYL)-, HYDROCHLORIDE (1:1)
Systematic Name English
GSK2269557
Code English
Code System Code Type Description
CAS
1254036-77-5
Created by admin on Tue Apr 01 17:10:09 GMT 2025 , Edited by admin on Tue Apr 01 17:10:09 GMT 2025
PRIMARY
MANUFACTURER PRODUCT INFORMATION
GSK-2269557
Created by admin on Tue Apr 01 17:10:09 GMT 2025 , Edited by admin on Tue Apr 01 17:10:09 GMT 2025
PRIMARY MedKoo CAT NO: 522375CAS NO: 1254036-77-5(HCl salt), 1254036-71-9(free base)Description: GSK-2269557 is a potent and selective PI3K.DELTA. inhibitor. GSK-2269557 is is currently in clinical trials for the treatment of respiratory diseases such as asthma and COPD. GSK-2269557 is highly selective for PI3K.DELTA. over the closely related isoforms and are active in a disease relevant brown Norway rat acute OVA model of Th2-driven lung inflammation. PI3K.DELTA. is highly enriched in leukocytes, making it an attractive target for the treatment of inflammatory conditions, such as asthma,6 chronic obstructive pulmonary disease (COPD), and autoimmune diseases. (last updated: 9/3/2015).
ChEMBL
CHEMBL3545250
Created by admin on Tue Apr 01 17:10:09 GMT 2025 , Edited by admin on Tue Apr 01 17:10:09 GMT 2025
PRIMARY
SMS_ID
100000175665
Created by admin on Tue Apr 01 17:10:09 GMT 2025 , Edited by admin on Tue Apr 01 17:10:09 GMT 2025
PRIMARY
FDA UNII
II4WQU7U3O
Created by admin on Tue Apr 01 17:10:09 GMT 2025 , Edited by admin on Tue Apr 01 17:10:09 GMT 2025
PRIMARY
PUBCHEM
49784084
Created by admin on Tue Apr 01 17:10:09 GMT 2025 , Edited by admin on Tue Apr 01 17:10:09 GMT 2025
PRIMARY